InvestorsObserver is giving Meridian Bioscience, Inc. (VIVO) an Analyst Rating Rank of 74, meaning VIVO is ranked higher by analysts than 74% of stocks. The average price target for VIVO is $28 and analyst’s rate the stock as a Strong Buy.
Wall Street analysts are rating VIVO a Strong Buy today. Find out what this means to you and get the rest of the rankings on VIVO!